In summary, while both medications offer benefits for type 2 diabetes and weight management, tirzepatides dual receptor agonism may provide enhanced glycemic control and weight loss outcomes compared to semaglutide
Its chemical structure, unlike semaglutide, has an Arginine-Lysine substitution at position 34 and a fatty acid residue is attached to Lysine 26
Christopher Sparrow, MD, is an Advanced heart failure cardiologist with OSF HealthCare
doi: 10.1136/openhrt-2018-001003 94
For example, a Maine woman filed a class action lawsuit against Cigna, alleging the insurer wrongfully denied coverage for an obesity drug and violated the Affordable Care Acts anti-discrimination protections
Combining Mounjaro with other weight loss medications can increase the risk of side effects like nausea, vomiting, or digestive issues